SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccesso Technology Group Regulatory News (ACSO)

Share Price Information for Accesso Technology Group (ACSO)

Share Price is delayed by 15 minutes
Get Live Data
327.00    -1.00 (-0.30%)
Bid:
326.50
Ask:
327.50
Spread: 1.00 (0.306%)
Market Cap: £105.92m
ACSO Live PriceLast checked at - London Stock Exchange

Intraday Accesso Technology Group Share Chart

Form 8.5 (EPT/RI) - Accesso Technology Group plc

5 Nov 2019 11:19

RNS Number : 3303S
Canaccord Genuity Limited
05 November 2019
Β 

FORM 8.5 (EPT/RI)

Β 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Name of exempt principal trader:

Canaccord Genuity Limited

Β 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Accesso Technology Group PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

Connected party to the Offeree

Β 

(d) Date dealing undertaken:

4 November 2019

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

No

Β 

Β 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchases/ sales

Β 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Β 

ORD 1P

Β 

Buy

Β 

Β 

5,578

Β 

Β 

590p

Β 

Β 

590p

Β 

(b) Derivatives transactions (other than options)

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Β 

Β 

Β 

(c) Options transactions in respect of existing securities

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercising

Β 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

3. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

NONE

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

NONE

Β 

Date of disclosure:

5 November 2019

Contact name:

Sam Holland

Telephone number:

020 7523 8337

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
FERUGGQGGUPBGGA
Date   Source Headline
5th Jun 20267:00 amRNSHolding(s) in Company
28th May 20266:00 pmRNSHolding(s) in Company
28th May 20267:00 amRNSResult of AGM
18th May 20267:00 amRNSDirector/PDMR Shareholding
1st May 20267:00 amRNSChief Executive Officer Succession
29th Apr 20267:00 amRNSAnnual Report and Notice of AGM
22nd Apr 20267:00 amRNSAppointment of Non-Executive Director
1st Apr 20267:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSAcquisition of Dexibit
30th Mar 20267:00 amRNSFinal Results
20th Mar 20266:05 pmRNSHolding(s) in Company
18th Mar 20264:54 pmRNSCompletion of Tender Offer & Total Voting Rights
13th Mar 20261:34 pmRNSResult of Tender Offer
13th Mar 20261:28 pmRNSResult of General Meeting
11th Feb 20267:00 amRNSTender Offer
10th Feb 20267:00 amRNS-RExpansion of Strategic Partnership with Adyen
6th Feb 20263:06 pmRNSDirector/PDMR Shareholding
2nd Feb 20267:00 amRNSTotal Voting Rights
29th Jan 20267:00 amRNSTrading Update and Tender Offer
9th Jan 20265:30 pmRNSHolding(s) in Company
8th Jan 20267:00 amRNSDirector/PDMR Shareholding
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTrading Update
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
23rd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20256:02 pmRNSHolding(s) in Company
22nd Dec 20256:02 pmRNSHolding(s) in Company
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20257:00 amRNSTransaction in Own Shares
15th Dec 202511:33 amRNSHolding(s) in Company
15th Dec 20257:00 amRNSTransaction in Own Shares
12th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20257:00 amRNSTransaction in Own Shares
10th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSTotal Voting Rights
1st Dec 20257:00 amRNSTransaction in Own Shares
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.